# Phase 1 Renal Insufficiency trials recruiting: 46 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 46 trials in phase 1 for Renal Insufficiency that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 1 Renal Insufficiency trials: 46 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 4 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-1/renal-insufficiency

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 46
- Recruiting or not yet: 46
- Read on: November 19, 2026

## Trials

The 25 newest of 46, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07946068 | Aleniglipron Renal Impairment Study | Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics | Phase 1 | Not yet recruiting | Renal Impairment, Severe Renal Impairment | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946068) |
| November 16, 2026 | NCT07938034 | A Study of SYH2053 Injection in Participants With Renal Impairment Compared to Participants With Normal Renal Function | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | Phase 1 | Recruiting | Renal Impairment | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07938034) |
| November 12, 2026 | NCT07933848 | A Study to Learn About the Study Medicine Called Prifetrastat in People With Renal Impairment | Pfizer | Phase 1 | Not yet recruiting | Renal Impairment, Healthy Adults | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07933848) |
| November 9, 2026 | NCT07924930 | A Study of Tersolisib (LY4064809) in Participants With Kidney Impairment Compared With Participants With Normal Kidney Function | Scorpion Therapeutics, a wholly owned subsidiary of Eli Lilly and Company | Phase 1 | Not yet recruiting | Renal Insufficiency, Healthy Participant | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07924930) |
| November 6, 2026 | NCT07923071 | A Study to Assess the Pharmacokinetics and Safety of Revumenib in Participants With Advanced Cancer and Hepatic or Renal Impairment | Syndax Pharmaceuticals | Phase 1 | Not yet recruiting | Relapsed/Refractory (R/R) Hematologic Malignancies, Acute Leukemia, Refractory Leukemia, Relapsed Leukemia | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923071) |
| November 6, 2026 | NCT07922174 | A Clinical Trial of MK-6916 in Participants With Moderate and Severe Kidney Disease Compared to Healthy Controls (MK-6916-013) | Merck Sharp & Dohme LLC | Phase 1 | Not yet recruiting | Healthy, Renal Impairment | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922174) |
| October 28, 2026 | NCT07901933 | Study of CTX001 in Adults With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease | Cajal Therapeutics Inc. | Phase 1 | Not yet recruiting | Chronic Kidney Disease, Anemia | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07901933) |
| October 9, 2026 | NCT07867171 | A Study to Investigate the Effects of Moderate or Severe Renal Impairment (RI) on Velzatinib | GlaxoSmithKline | Phase 1 | Not yet recruiting | Healthy Participants, Gastrointestinal Neoplasms | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07867171) |
| October 5, 2026 | NCT07857837 | Study of Sulthiame (S-054502) in Participants With Renal Impairment and Matched Healthy Controls | Shionogi | Phase 1 | Not yet recruiting | Renal Impairment | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07857837) |
| October 2, 2026 | NCT07854249 | A Study to Evaluate the Pharmacokinetics and Safety of INCB161734 in Participants With Impaired Renal Function and Participants on... | Incyte Corporation | Phase 1 | Not yet recruiting | Renal Insufficiency, Kidney Diseases | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07854249) |
| October 1, 2026 | NCT07853131 | Study to Assess the Plasma Concentration of Rilzabrutinib Given as a Tablet to Adult Participants With Severe Renal Impairment Compared to... | Sanofi | Phase 1 | Recruiting | Renal Impairment, Healthy Volunteers | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07853131) |
| September 9, 2026 | NCT07808788 | A Research Study Looking Into How a Single Dose of the Medicine NNC0537-1482 Moves Through the Body of Participants With Normal or Reduced... | Novo Nordisk A/S | Phase 1 | Not yet recruiting | Chronic Kidney Disease | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07808788) |
| September 1, 2026 | NCT07797322 | A Study to Investigate the Pharmacokinetics and Safety of PKN605 in Participants With Moderate and Severe Renal Impairment Compared to... | Novartis Pharmaceuticals | Phase 1 | Recruiting | Participants With Moderate and Severe Renal Impairment and Healthy Participants | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07797322) |
| August 31, 2026 | NCT07793929 | A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide | Kailera | Phase 1 | Recruiting | End Stage Renal Disease, Renal Impairment, Obesity, Overweight | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07793929) |
| August 12, 2026 | NCT07759167 | Study of 3 Monoclonal Antibodies (REGN9933, REGN7508, and REGN9533) in Adult Participants With End-Stage Kidney Disease on Hemodialysis | Regeneron Pharmaceuticals | Phase 1 | Recruiting | End-Stage Kidney Disease (ESKD) | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07759167) |
| August 11, 2026 | NCT07758608 | Renal Impairment Pharmacokinetics (PK) Trial of Afabicin | Debiopharm International SA | Phase 1 | Recruiting | Renal Impairment | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07758608) |
| August 3, 2026 | NCT07741604 | A Study Investigating the Safety of RO7795081 and How the Body Processes RO7795081 in People With Normal or Decreased Kidney Functions | Hoffmann-La Roche | Phase 1 | Recruiting | Renal Impairment | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07741604) |
| August 3, 2026 | NCT07741136 | Pharmacokinetics of Zoledronic Acid in Patients on Dialysis | University of Campinas, Brazil | Phase 1 | Not yet recruiting | Chronic Kidney Disease, Osteoporosis, Dialysis | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07741136) |
| July 29, 2026 | NCT07734610 | A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027) | Merck Sharp & Dohme LLC | Phase 1 | Recruiting | Severe Renal Impairment, Healthy | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07734610) |
| July 20, 2026 | NCT07715175 | The Study is to Investigate D-2570 in Participants With Different Levels of Kidney Function. | InventisBio Co., Ltd | Phase 1 | Recruiting | Renal Impairment | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07715175) |
| July 16, 2026 | NCT07708038 | Anti-Interleukin-6 (IL6) in Calciphylaxis | Boston Medical Center | Phase 1 | Not yet recruiting | Calciphylaxis | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07708038) |
| July 10, 2026 | NCT07694544 | Renal Impairment Study for Oral EC5026 | EicOsis Human Health Inc. | Phase 1 | Recruiting | Chronic Kidney Disease | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07694544) |
| June 1, 2026 | NCT07619157 | A Study of ONO-3310 in Healthy Adult Male Subjects and Chronic Kidney Disease Patients With Type 2 Diabetes Mellitus | Ono Pharmaceutical Co., Ltd. | Phase 1 | Recruiting | Type2 Diabetes Mellitus, Chronic Kidney Disease | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07619157) |
| May 29, 2026 | NCT07615985 | Phase 1a Study Assessing Safety, Tolerability, Pharmacokinetics, and Immunogenicity of PMG1016 | Pulmongene Ltd. | Phase 1 | Recruiting | Chronic Kidney Disease | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07615985) |
| May 7, 2026 | NCT07572890 | Adia Med of Winter Park LLC Chronic Kidney Disease Research Study | Adia Med of Winter Park LLC | Phase 1 | Recruiting | Chronic Kidney Disease, Kidney Disease, Kidney Disease, Chronic, Chronic Kidney Disease (CKD), CKD | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07572890) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 2 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 2 |
| [Incyte Corporation](https://specstream.ai/data/clinical-trials/company/incyte-corporation) | 2 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 2 |
| Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics | 1 |
| [Ono Pharmaceutical Co., Ltd.](https://specstream.ai/data/clinical-trials/company/ono-pharmaceutical-co-ltd) | 1 |
| University of Campinas, Brazil | 1 |
| [Beijing Continent Pharmaceutical Co, Ltd.](https://specstream.ai/data/clinical-trials/company/beijing-continent-pharmaceutical-co-ltd) | 1 |
| [Debiopharm International SA](https://specstream.ai/data/clinical-trials/company/debiopharm-international-sa) | 1 |
| Washington University School of Medicine | 1 |
| Consun Pharmaceutical Group | 1 |
| Cajal Therapeutics Inc. | 1 |
| Noucor Health S.A. | 1 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 1 |
| Qianfoshan Hospital | 1 |
| Emory University | 1 |
| The First Affiliated Hospital with Nanjing Medical University | 1 |
| Adia Med of Winter Park LLC | 1 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 1 |
| Regend Therapeutics | 1 |
| Boston Medical Center | 1 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 1 |
| Pulmongene Ltd. | 1 |
| [Shionogi](https://specstream.ai/data/clinical-trials/company/shionogi) | 1 |
| [CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.](https://specstream.ai/data/clinical-trials/company/cspc-zhongnuo-pharmaceutical-shijiazhuang-co-ltd) | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 22 |
| China | 9 |
| Germany | 3 |
| Australia | 3 |
| Japan | 1 |
| Brazil | 1 |
| Portugal | 1 |
| Spain | 1 |
| Belgium | 1 |
| United Kingdom | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Ice suppliers in the United States](https://specstream.ai/data/businesses/ice-suppliers/united-states)
- [Lighting fixture manufacturers in the United States](https://specstream.ai/data/businesses/lighting-fixture-manufacturers/united-states)
- [Neurology practices in the United States](https://specstream.ai/data/businesses/neurology-practices/united-states)
- [Pipe suppliers in the United States](https://specstream.ai/data/businesses/pipe-suppliers/united-states)
- [Remodeling contractors in the United States](https://specstream.ai/data/businesses/remodeling-contractors/united-states)
- [Spring suppliers in the United States](https://specstream.ai/data/businesses/spring-suppliers/united-states)
